ST Cabio: Discloses Progress on Other Risk Warning, Cautions of Delisting Risk

ST Cabio announced that due to overseas market public opinion and new regulatory requirements, the company's production and operations have been severely affected and are not expected to return to normal within 3 months. Its shares have been subject to other risk warnings since July 28, 2026. Currently, the company is advancing supply chain upgrades, business recovery, and the commercialization of synthetic biology achievements. In September, it completed the delivery of some algal oil DHA export orders and was selected for the preliminary list of the first batch of national emerging industry development demonstration bases created by the Ministry of Industry and Information Technology. There is uncertainty regarding the timing of the company's business recovery. If full-year revenue for 2026 is less than 100 million yuan, it may be subject to a delisting risk warning.